Chelation therapy for lead is a medical treatment that uses specific drugs to bind lead in the body and pull it out through urine or stool. It’s reserved for significant lead poisoning, typically when blood lead levels reach 45 micrograms per deciliter (µg/dL) or higher in children. The treatment works, but it comes with real risks and limitations, so it’s only used when the level of poisoning justifies those tradeoffs.
How Chelation Works in the Body
A chelating agent is a molecule designed to latch onto a specific metal ion and form a stable complex with it. Once bound, the lead-chelate complex dissolves more easily in body fluids than lead alone, allowing the kidneys or digestive system to flush it out. Think of it like a chemical escort: the drug finds lead particles, wraps around them, and carries them to the exit.
The reality inside the body is more complicated than that simple picture. Lead doesn’t sit in one convenient spot. It circulates in the blood, accumulates in soft tissues like the brain and kidneys, and over time gets stored deep in bone. Chelating agents work best on lead that’s circulating in the blood or sitting in soft tissue. Lead locked in bone is much harder to reach, which is one reason treatment can take multiple rounds.
When Chelation Is Recommended
The CDC uses a blood lead level of 45 µg/dL or higher as the point where healthcare providers may recommend chelation for children. Below that level, the standard approach focuses on finding and eliminating the lead source, improving nutrition (especially iron and calcium, which compete with lead for absorption), and monitoring blood levels over time.
At very high levels, the calculus shifts. Blood lead above 70 µg/dL in children or above 100 µg/dL in adults, or any case involving lead encephalopathy (swelling in the brain), calls for aggressive treatment, often in a hospital setting. Chelation should never be given while the person is still being exposed to lead, because the drugs can actually increase how much lead the gut absorbs. Before treatment begins, the source of exposure has to be identified and the patient removed from it. For children, that means an environmental investigation and cleanup of the home or other contaminated setting.
The Three Main Chelating Drugs
Succimer (DMSA)
Succimer is the most commonly prescribed chelating agent today. It’s taken by mouth, which makes it far more practical than the alternatives. It’s approved for children with blood lead levels above 45 µg/dL. A typical course for children ages 1 to 11 lasts 19 days: the medication is given every eight hours for the first five days, then every twelve hours for the remaining fourteen days. Adults follow a similar weight-based dosing schedule. Because it’s an oral medication, succimer can sometimes be managed on an outpatient basis, though close medical monitoring is still required.
Calcium Disodium EDTA
Calcium EDTA has been in use since 1953 and remains a frontline option for severe cases. It’s given by injection, either into a vein or into muscle, and is equally effective by either route. For patients with lead encephalopathy, the intramuscular route is preferred. Because it’s excreted almost entirely through the kidneys, doctors need to make sure the patient is producing enough urine before starting treatment. Patients who are dehydrated from vomiting, which is common in acute lead poisoning, typically receive IV fluids first.
Dimercaprol (BAL)
Dimercaprol is the oldest chelating agent in this group, developed in 1945. It’s reserved for the most dangerous situations: severe symptomatic poisoning, lead encephalopathy, or extremely high blood lead levels. It’s given by deep intramuscular injection and is always used in combination with calcium EDTA rather than alone. The critical detail is timing: dimercaprol must be given before the calcium EDTA, and at a different injection site. This sequencing prevents lead from being redistributed into the brain during treatment. The drug is formulated with peanut oil, which means it’s not an option for people with peanut allergies.
What Treatment Looks Like
For moderate cases treated with oral succimer, the experience is relatively straightforward. You take capsules at home for about three weeks, with regular blood draws to track your lead levels and kidney function. The medication has a sulfur-like smell and taste that some people find unpleasant.
Severe cases look very different. Hospitalization is typically necessary when injectable chelators are used. A child with lead encephalopathy might be in the hospital for several days receiving injections every four hours around the clock. Fluid balance has to be carefully managed, because too much fluid in a patient with brain swelling can make things worse, while too little fluid impairs the kidneys’ ability to clear the lead-drug complex.
Regardless of which drug is used, blood lead levels are rechecked after treatment ends. It’s common for levels to drop during a course of chelation and then partially rise again afterward. This rebound happens because lead stored in bone slowly leaches back into the bloodstream once the chelating drug is no longer present. Multiple treatment courses are sometimes needed, with waiting periods in between to allow redistribution and reassessment.
Risks and Side Effects
Chelation therapy isn’t benign. The same chemical properties that let these drugs grab lead also make them capable of pulling out essential minerals like zinc, copper, and iron. Mineral depletion is a real concern, especially with repeated courses of treatment.
Kidney damage is the most serious risk. Calcium EDTA in particular can cause acute tubular necrosis, a form of kidney injury, if not dosed carefully or if the patient is dehydrated. Kidney function is monitored throughout treatment with blood and urine tests. Complete blood counts, iron levels, and other lab work are also tracked, especially in children.
Dimercaprol carries its own set of side effects, including nausea, vomiting, elevated blood pressure, and pain at the injection site. It’s the harshest of the three options, which is why it’s only used when the poisoning is life-threatening.
Why Removing the Lead Source Comes First
Chelation treats the lead already in the body, but it does nothing to stop new lead from getting in. If a child returns to a home with peeling lead paint or contaminated dust, their blood levels will climb right back up. The treatment becomes a revolving door.
This is why guidelines emphasize environmental investigation and remediation before or alongside medical treatment. For children, this means identifying the lead source, whether it’s deteriorating paint in an older home, contaminated soil, imported spices or ceramics, or lead-contaminated water. The child should not return to the environment until the hazard has been addressed. Chelation given during ongoing exposure is not just ineffective but potentially harmful, because some chelating agents can increase lead absorption from the gut.
What Chelation Can and Cannot Do
Chelation reliably lowers blood lead levels and can reverse some acute symptoms of poisoning, like abdominal pain, vomiting, and in severe cases, seizures and brain swelling. What it cannot do is undo damage that has already occurred. Lead’s most devastating effects in children involve neurodevelopment: lower IQ, attention problems, and behavioral difficulties. These changes result from lead interfering with brain development during critical windows, and chelation after the fact does not restore lost cognitive function.
This is one reason chelation remains controversial for mildly elevated lead levels. At lower blood concentrations, the potential benefits of chelation are modest, while the risks of side effects remain. For children with levels between about 20 and 44 µg/dL, the priority is source removal, nutritional support, and close follow-up rather than medication. Chelation is a tool for acute medical crisis management, not a cleanup of low-level chronic exposure.